Older age, prior C diff infection events are factors in treatment failure.

Findings from the largest ever study of device-measured physical activity and cardiovascular disease highlight protective benefits of exercise.

Post-anthracycline statin exposure is linked to reduced HF hospitalization.

The ACTIV-2 trial will initially enrol 220 participants with mild or moderate COVID-19 who are at risk for disease progression.

The latest stories you need to know.

COVID-19 Around the world weekly highlights: Israel leading the vaccination race, new virus variants...

More than half of the patients reported ongoing poor health, despite normal chest X-rays.

Findings from a cross-sectional analysis.

Even virtual interactions might reduce risk.

This cohort study examined exposure to household unemployment, incarceration, mental disorders, death, and divorce and the child’s foster care experiences.

Early treatment cuts risk by 48% in older patients with mild disease.

Findings suggest this antibiotic should be used with caution among all adults age 35 years or older.

The latest stories you need to know.

Healthcare professionals are asked to report inconsistencies in UK advice in this area.